About the Pharmaceutical Nano Systems Session
Nanotechnology has been a revolutionary field of science that has enabled the development of incredibly small machines and devices. In the field of Pharmaceutical, the use of nanotechnology has enabled the development of innovative drug delivery systems, known as pharmaceutical nano systems. These systems are designed to increase the effectiveness of drug delivery and decrease the amount of time it takes for the drug to reach its target. Pharmaceutical nano systems can be divided into two categories: those designed for passive drug delivery and those designed for active drug delivery. The first type of pharmaceutical nano system is designed for passive drug delivery. This system is designed to passively transport drugs to their target site. This is done by using nanoscale particles, such as liposomes, polymers and nanoparticles, which can easily transport drugs to the target site. The advantage of this system is that it allows for more efficient drug delivery, with fewer side effects. The second type of pharmaceutical nano system is designed for active drug delivery. These systems are designed to actively deliver drugs to their target site. This is accomplished by using nanoscale devices, such as micro-pumps, nanorobots and nanosensors. These devices are able to precisely deliver drugs to the target site, and can even be programmed to deliver drugs in a specific order. The advantage of this system is that it can increase the efficiency of drug delivery and can also be used to reduce side effects. Overall, pharmaceutical nano systems are an incredibly promising technology that can revolutionize the way drugs are delivered to their target site.
Topics Covered in Pharmaceutical Nano Systems
EPR Effect & Passive Targeting
Ligand-Mediated Active Targeting
Dendrimer Drug Conjugates
Self-Nanoemulsifying Drug Delivery
pH-Responsive Release Systems
Mesoporous Silica Drug Carriers
Related Scientific Sessions at World Nano 2027
Why Attend the Pharmaceutical Nano Systems Conference 2027
Earn CPD Credit
Participants can earn 1 CPD credit for each hour of attendance.
Present Your Research
Oral and poster slots for original Pharmaceutical Nano Systems work, reviewed by the scientific committee.
Network Globally
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
Abstract Book Included
In-person and virtual registrations include an electronic copy of the abstract book.
Learn from Keynotes
Plenary lectures from leading voices shaping Pharmaceutical Nano Systems research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join World Nano 2027 for the Pharmaceutical Nano Systems track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Pharmaceutical Nano Systems Conference 2027 — FAQs
What is the Pharmaceutical Nano Systems track at World Nano 2027?
The Pharmaceutical Nano Systems track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Pharmaceutical Nano Systems. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Pharmaceutical Nano Systems sessions?
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Pharmaceutical Nano Systems are all welcome — whether presenting or attending.
Can I present my research in the Pharmaceutical Nano Systems track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Pharmaceutical Nano Systems sessions?
Yes. World Nano 2027 is a hybrid conference — attend the Pharmaceutical Nano Systems track in person in Singapore or join live online, with on-demand access afterward.
Join the World Nano 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.